Related Experiment Video
Updated: Sep 6, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
How I Treat Pediatric Hematology-Oncology Patients from Families Identifying as Jehovah's Witnesses
Meaghann S Weaver1, Clifford Takemoto2, Liza Marie Johnson2
1St Jude Children's Research Hospital, Memphis, Tennessee, United States.
Abstract:
Caring for pediatric hematology-oncology patients from families identifying as Jehovah's Witnesses presents opportunities to align clinical and ethical care considerations, particularly regarding blood transfusion refusal. Although transfusion avoidance is often presumed, patient and family preferences are heterogeneous and influenced by individual conscience, cultural context, and interpretation religious guidance. This article explores practical approaches to transfusion‑averse care through three illustrative cases. The first involves an adolescent with relapsed Hodgkin lymphoma considering autologous hematopoietic cell transplantation, highlighting tensions between emerging autonomy, deeply held beliefs, and standard‑of‑care oncology practices. The second examines an infant with severe aplastic anemia, illustrating intrafamilial disagreement, the role of surrogacy and delegation of consent, and circumstances justifying legal intervention to protect a child's best interests. The third case involves chronic transfusions and underscores the longitudinal nature of decision-making. We review the doctrinal framework underlying the cases, emphasize the importance of assessing the depth and personal ownership of beliefs, and outline evidence‑based strategies to reduce transfusion exposure, including anemia mitigation, bleeding prophylaxis, and blood conservation techniques. The article also addresses ethical thresholds, use of preemptive court orders, and communication practices that preserve trust and minimize moral distress. Thoughtful, proactive, and individualized care (grounded in ethical humility, data‑driven assessment, and interdisciplinary collaboration) can honor religious beliefs while maintaining safe, patient‑centered outcomes.
Related Concept Videos
Treatment Resistant Cancers
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Treatment Resistent Cancers
Hemodialysis III: Nursing Management
Hemodialysis I: Introduction
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
